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Study Objectives: Physiological adaptation to high altitude hypoxia may be impaired in Andeans with significant European ancestry. The respiratory ‘burden’ 
of sleep may challenge adaptation, leading to relative nocturnal hypoxia. Developmental aspects of sleep-related breathing in high-altitude native children 
have not previously been reported. We aimed to determine the influence of development on diurnal-nocturnal oxyhemoglobin differences in children living at 
high altitude.
Methods: This was a cross-sectional, observational study. Seventy-five healthy Bolivian children aged 6 mo to 17 y, native to low altitude (500 m), moderate 
high altitude (2,500 m), and high altitude (3,700 m) were recruited. Daytime resting pulse oximetry was compared to overnight recordings using Masimo 
radical oximeters. Genetic ancestry was determined from DNA samples.
Results: Children had mixed European/Amerindian ancestry, with no significant differences between altitudes. Sixty-two participants had ≥ 5 h of nocturnal, 
artifact-free data. As predicted, diurnal mean oxyhemoglobin saturation decreased across altitudes (infants and children, both P < 0.001), with lowest 
diurnal values at high altitude in infants. At high altitude, there was a greater drop in nocturnal mean oxyhemoglobin saturation (infants, P < 0.001; children, 
P = 0.039) and an increase in variability (all P ≤ 0.001) compared to low altitude. Importantly, diurnal to nocturnal altitude differences diminished (P = 0.036), 
from infancy to childhood, with no further change during adolescence.
Conclusions: Physiological adaptation to high-altitude living in native Andeans is unlikely to compensate for the significant differences we observed between 
diurnal and nocturnal oxyhemoglobin saturation, most marked in infancy. This vulnerability to sleep-related hypoxia in early childhood has potential lifespan 
implications. Future studies should characterize the sleep- related respiratory physiology underpinning our observations.
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INTRODUCTION
Physiological adaptation to high-altitude (HA) hypoxia is crit-
ical for the 140 million people who live 2,500 m or more above 
sea level.1 As altitude increases, atmospheric pressure drops, 
resulting in a fall in inspired oxygen, such that populations 
living above 4,000 m breathe air containing only ~60% of the 
oxygen found at sea level (Figure 1).
The ancestors of native Andeans settled on HA plains ap-
proximately 11,000 years ago. Over this time their physiology 
evolved to compensate for HA hypoxia, principally through 
erythrocytosis and an increase in pulmonary artery pressure, 
diffusion capacity, and total lung capacity.2 Spanish coloniza-
tion, half a century ago, diluted the Amerindian gene pool and 
threatened this adaptation. This may explain the 15% preva-
lence of chronic mountain sickness2 (a triad of extreme poly-
cythaemia, hypoxia, and impaired right heart function) and 
reduced life expectancy3 in this population.
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Significance
This is the first study to report significant differences between diurnal and nocturnal oxyhaemoglobin in infants and children resident at high altitude. 
These differences are dramatic in infants, where oxyhaemoglobin saturation is also unstable, but improve in childhood. Urban Andean high altitude 
dwelling populations have significant European ancestry and sleep physiology may challenge an already constrained system. Whether reduction 
in tissue oxygen delivery is clinically significant requires further study. Intermittent nocturnal hypoxia in obstructive sleep apnoea in children living 
at sea-level, has long-term consequences for cognitive performance and cardiovascular health. We hypothesise that exposure to low nocturnal 
oxyhaemoglobin may contribute to the subtle psychomotor slowing we have demonstrated in Andean high altitude dwelling children.
Research into native HA respiratory physiology has 
largely overlooked the challenge that the sleep state pres-
ents to an already constrained system, specifically through 
decreased minute ventilation, increased upper airway resis-
tance, and reduction in the slopes of the ventilatory response 
curves to hypoxemia and hypercapnia. This is particularly 
important in children who sleep more than adults and in 
whom early exposure to hypoxia may affect life-long car-
diovascular status.4 Furthermore, developmental studies of 
HA natives5,6 have consistently shown that mean daytime 
oxyhemoglobin saturation (SpO2) increases across the first 
decade of life. Bolivian adolescents at 3,900–4,000 m had 
daytime SpO2 values of 92.7% (females) and 93.3% (males)7 
compared to only 87.3% in children younger than 5 y. We, 
therefore, hypothesized that nocturnal SpO2 would also re-
flect developmental adaptation in HA compared to low-alti-
tude (LA) native children.
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METHODS
Data were collected across two consecutive research expe-
ditions examining cognitive function at high altitude, and 
included 547 infants, children, and adolescents. Study 1 re-
cruited children aged 6–10 y from: Santa Cruz (LA), at 500 m; 
Cochabamba, moderate altitude (MA) at 2,500 m, and La Paz 
(HA), at 3,700 m.8 Study 2 recruited participants aged 6 mo 
to 17 y from LA and HA only.9 Children were sampled from 
three discrete age groups: infancy, mid-childhood (4–10 y) and 
adolescence (13–16 y). The physiological measures of interest 
reported here are ancillary oximetry studies involving a subset 
of the total study sample. Ethics committee approval was 
granted by the University of Southampton, UK and Univalle, 
Bolivia (Study 1), and by Universidad Privada Abierta Lati-
noamericana, Bolivia and the University of Western Australia 
(Study 2). Parents provided written informed consent for their 
child’s participation.
Inclusion criteria were consistent across studies.8,9 Partici-
pants were healthy with no developmental disorders and had 
been born at, and lived continuously at, the altitude location for 
at least the year prior to study. In both studies, all children at-
tended a research center during the day, and parents provided 
information on maternal education, and their child’s medical 
and developmental history. Physical examination was over-
seen by physicians and included anthropometry (height and 
weight), clinical cardiorespiratory examination, and resting 
blood pressure (Microlife, Zurich). Weight for length centiles 
(infants) and body mass index centiles (children and adoles-
cents) were derived from standard US growth charts. Systolic 
blood pressure centiles were computed for children and ado-
lescents.10 Proportion of Native American, European, and Af-
rican genetic ancestry was determined from DNA samples as 
previously described.8,9
Diurnal Measures
Resting pulse oximetry was sampled using a Masimo Radical 
oximeter (Masimo Corp, Irvine, CA). End-tidal carbon dioxide 
(ETCO2; nasal cannulae) was measured in children and ado-
lescents only (TIDALWAVE: Philips Respironics, Murrysville, 
PA, USA). Participants were required to relax and breathe 
steadily at rest for 3 min to achieve steady baseline ETCO2 
values, and readings were only made from the device if an ex-
piratory plateau was present.
Nocturnal Measures
Pulse oximetry was sampled for 1 night at home using a Ma-
simo Radical oximeter with a 2-sec averaging time. Parents 
were trained in use of the device at the research center and 
detailed step-by-step instructions, supplemented with images, 
were provided. Parents were instructed to start the recording 
when the child had settled to sleep and stop recording when the 
child finally woke in the morning. Data were analyzed using 
Download 2001 software (Stowood Scientific, Oxford, UK). 
Poor perfusion, low signal quality, and movement artefact data 
were rejected, as were recordings < 5 h duration.11 Variables 
generated included mean SpO2; delta-12-sec index (the abso-
lute difference between successive 12-sec interval recordings); 
desaturation indices of > 3%/h; and time in minutes with SpO2 
below 90% and 80%.
Analysis
Data were analyzed in SPSS version 22 (IBM). Given that data 
were not available at all age groups and all altitudes, analyses 
were conducted within altitudes, by age-group and time-of-day, 
or within age-groups, by altitude and time-of-day. For infants 
and children, in whom we had diurnal and nocturnal measure-
ments at low and high altitude, we conducted a full-factorial, 
three-way analysis. Simple age-group or altitude differences 
were explored using Kruskal-Wallis or Jonkheere trend tests 
(where ordered differences were predicted) given the non-nor-
mality of some variables. For analyses exploring interaction 
terms, for which there is no non-parametric alternative, anal-
ysis of variance (ANOVA, univariate or repeated measures) 
were conducted and then non-parametric comparisons were 
run to confirm significant effects. Given the exploratory nature 
of these analyses, adjustments to P values for post hoc analyses 
were not made, to reduce the risk of a type 2 error.12,13 Partial 
eta-squared effect sizes (η2p) were computed for all ANOVA. 
Categorical group differences were explored using χ2 (Fisher 
exact) test.
RESULTS
Seventy-five overnight studies were performed (24 LA, 12 MA, 
and 39 HA), of which 62 (68.9%) had ≥ 5 h of artefact-free data 
(21 LA, 9 MA, and 32 HA).
Demographic Variables
There were no sex by altitude differences overall, Fisher exact 
test, P = 0.299, nor altitude differences within age groups. 
Two HA babies were born at 36 w and one baby at LA at 32 
w gestation; chronological age was adjusted in these infants. 
All children were healthy, developing typically and from 
Figure 1—Partial pressure of inspired oxygen (PiO2) as a percentage of 
sea-level values at increasing altitudes. Altitudes at which participants 
were recruited in this study (500 m, 2,500 m, > 3,650 m) and in other 
studies (A: Burg et al.22, at 1,600 m; B: Coote et al.19, Spicuzza et al.20, 
at 4,380 m) are shown. The solid line represents inspired oxygen in 
mmHg (left hand y axis) and the dashed line represents percent of 
inspired oxygen compared to sea-level values (right hand y axis). 
Figure adapted from: Beall et al.7 Copyright (2007) National Academy 
of Sciences, USA.
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middle-to-high social strata, with no altitude differences in 
maternal educational level. Ancestry informative markers re-
vealed no altitude differences, F < 1, and a significant propor-
tion of European ancestry (Table 1). This analysis was repeated 
within age groups, and revealed no altitude differences in ge-
netic admixture, all P > 0.34.
Clinical Measures
Parents reported asthma in two children at LA and one ado-
lescent at HA. There were no significant differences in resting 
daytime ETCO2 across altitudes. Regular snoring was reported 
in 21% of children (Table 1), with apnea symptoms in one HA 
child. One LA and 2 HA children had systolic blood pressure 
readings at, or above, the 95th centile, but there were no alti-
tude-related differences in the distribution of children across 
the systolic blood pressure centiles, Fisher exact test, P = 0.614. 
Cardiorespiratory examination was normal in all participants. 
Eleven percent of children were obese, but this was not influ-
enced by altitude location, P = 0.339.
Diurnal Pulse Oximetry Measures
As predicted, there were statistically significant trends of 
lower median diurnal SpO2 with increasing altitude in infants 
(from LA to HA), TJT = 18.0, z = −5.6, P < 0.001, and in chil-
dren (from LA, to MA, to HA), TJT = 0, z = −3.5, P < 0.001, 
confirmed by significant pairwise comparisons, all P ≤ 0.001 
(Table 2).
Within altitude, there were no developmental differences, 
in that diurnal SpO2 did not vary with age at LA, TJT = 62.5, 
z = 1.7, P = 0.097, or at HA, TJT = 177.5, z = 1.1, P = 0.291.
Nocturnal Pulse Oximetry Recordings
For overnight studies, the mean duration of data analyzed 
did not differ between age or altitude groups. Pulse rate as 
Table 1—Demographic and clinical data by altitude.
Low Altitude (n = 21) Moderate Altitude (n = 9) High Altitude (n = 32)
Sex, M/F 10/11 6/3 22/10
Age, n: mean ± SD months/year
Infants 6–12 months 12: 9.1 ± 2.7 7: 10.4 ± 2.2
Children 4–10 years 9: 8.4 ± 1.8 9: 8.1 ± 1.4 18: 8.7 ± 1.2
Adolescents 13–17 years 7: 13.8 ± 1.7
Mother completed education, age in years b 21 (4.5) 21 (0.5) 22 (4)
Ancestry informative markers, mean % (95% CI)
European 44.6 (39.8–48.5) 38.9 (35.3–42.6) 40.3 (37.2–43.4)
Native Andean 54.3 (50.0–58.7) 59.9 (56.3–63.5) 58.2 (55.1–61.4)
African 1.5 (1.3–1.8) 1.2 (1.1–1.3) 1.5 (1.3–1.7)
Weight centile infants, n
Underweight 2 2
Normal weight 10 2
Overweight 0 1
Obese 0 1
BMI centile, n
Children 4–10 years
Underweight 0 1
Normal weight 4 6 13
Overweight 1 2 3
Obese 4 1 1
Adolescents 13–17 years
Underweight 0
Normal weight 4
Overweight 2
Obese 1
Percentage of all ages overweight/obese 23.8 33.3 29.0
History of regular snoring, n
Infants 6–12 months 6 3
Children 4–10 years 1 1   3 c
Adolescents 13–17 years 0
Values presented as median (IQR) unless otherwise stated. a Ancestry analysis was conducted for just one child per family, hence n = 21, 10, and 33, 
for low, moderate, and high altitude, respectively. b n = 17, 9, and 22, respectively. c The parent of just one child, at high altitude, also reported symptoms 
suggestive of sleep apnea. BMI, body mass index; CI, confidence intervals; IQR, interquartile range; SD, standard deviation.
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measured by the SpO2 probe did not differ across altitudes, 
either in infants or in children, both χ2 < 1 (Table 2).
Mean SpO2 Data
Figure 2 illustrates differences between mean diurnal and noc-
turnal SpO2 measurements by age and altitude.
Within-Altitude Comparisons, by Time of Day and Age Group
At LA, there was a significant effect of time of day (diurnal, 
nocturnal), F(1,17) = 15.23, P = 0.001, η2p = 0.47, and a 
time of day by age group (infants, children) interaction, 
F(1,17) = 7.61, P = 0.013, η2p = 0.31, such that nocturnal 
measures were consistently lower than diurnal measures 
and this difference was slightly larger in children than 
in infants.
In comparison, at HA, as well as a main effect of time of day 
(diurnal, nocturnal), F(1,29) = 62.84, P < 0.001, η2p = 0.68, with 
nocturnal consistently lower than diurnal measures in all age 
groups, there was also a significant effect of age group (infants, 
children, adolescents), F(2,29) = 4.80, P = 0.016, η2p = 0.25 with 
infants showing a higher nocturnal drop in SpO2 than children 
or adolescents, who did not differ, but no interaction, F < 1.5.
Within Age Group Comparisons by Time of Day and Altitude
In infants, there was an effect of time of day (diurnal, nocturnal), 
F(1,15) = 35.95, P < 0.001, η2p = 0.71, with lower nocturnal 
Table 2—Oximetry and end-tidal carbon dioxide data.
Low Altitude (n = 21) Moderate Altitude (n = 9) High Altitude (n = 32)
Daytime SpO2 (%) a
Infants 6–12 months 99 (2) 94 (2)
Children 4–10 years 100 (1) 97 (2) 94 (1)
Adolescents 13–17 years 94 (2)
Daytime end-tidal CO2 (mmHg) b
Children 4–10 years 39 (4) 37.5 (3.8) 35.5 (7)
Adolescents 13–17 years 33 (4.5)
Night-time pulse oximetry 
Artefact-free data (min)
Infants 6–12 months 458.5 (113.9) 473.3 (151.3)
Children 4–10 years 476 (117.4) 491.4 (94.6) 495.5 (64.4)
Adolescents 13–17 years 439.1 (79.1)
Mean pulse rate
Infants 6–12 months 115.2 (12.5 ) 113 (11.6 )
Children 4–10 years 74.2 (7.0) 79.7 (13.7 ) 77.4 (14.2)
Adolescents 13–17 years 69.8 (3.1 )
Mean night-time SpO2 (%)
Infants 6–12 months 98.8 (0.7) 87.5 (7.7)
Children 4–10 years 98.1 (1.2) 93.7 (2.4) 90.3 (6.1)
Adolescents 13–17 years 91.2 (3.1)
Index of > 3% desaturation/h
Infants 6–12 months 2.2 (1) 55.8 (60.7)
Children 4–10 years 0.7 (1.6) 3.1 (3.3) 8.1 (4.7)
Adolescents 13–17 years 8.7 (8.7)
Delta 12s
Infants 6–12 months 0.4 (0.2) 1.6 (1.5)
Children 4–10 years 0.3 (0.1) 0.5 (0.2) 0.5 (0.1)
Adolescents 13–17 years 0.5 (0.2)
Percent time spent < 90% SpO2
Infants 6–12 months 0 (0) 79.7 (66.0)
Children 4–10 years 0 (0.2) 0.7 (1.6) 33.5 (76.2)
Adolescents 13–17 years 7.6 (63.9)
Percent time spent < 80% SpO2 c
Infants 6–12 months 0 (0) 1.8 (7.8)
Children 4–10 years 0 (0.1) 0 (0.1) 0 (0.2)
Adolescents 13–17 years 0 (0)
Values presented as median (IQR) unless otherwise stated. a n = 10 for LA children. b n = 8 for MA children, 5 for HA adolescents. c n = 17 for HA children. 
CO2, carbon dioxide; IQR, interquartile range; SpO2, oxyhemoglobin saturation.
SLEEP, Vol. 39, No. 5, 2016 1005 Developmental Nocturnal Hypoxia at Altitude—Hill et al.
oximetry, and of altitude (LA, HA), F(1,15) = 178.08, P < 0.001, 
η2p = 0.92, in which SpO2 was lower at HA. The significant time 
of day by altitude interaction, F(1,15) = 29.59, P < 0.001, η2p = 0.66 
was driven by a larger drop in nocturnal SpO2 in HA relative 
to LA infants. In children, the same effects were found across 
three altitudes: time of day (diurnal, nocturnal), F(1,33) = 47.00, 
P < 0.001, η2p = 0.59, altitude (LA, MA, HA), F(2,33) = 61.41, 
P < 0.001, η2p = 0.79, with SpO2 lowest at HA, highest at LA, and 
with MA intermediate. The significant time of day by altitude 
interaction, F(1,33) = 3.58, P = 0.039, η2p = 0.18, mirrored that 
seen in infants in that the differential between diurnal and noc-
turnal SpO2 increased with increasing altitude.
Three-Way Comparisons of Altitude, Age Group, and Time of Day
Importantly, a three-way ANOVA of age by altitude (LA, 
HA) by time of day in infants and children (no adolescent 
data available for LA) demonstrated that altitude-related dif-
ferences in diurnal and nocturnal mean SpO2 decrease with 
age; that is, they are reduced in children compared to infants, 
suggesting developmental adaptation: three-way interaction, 
F(1,40) = 4,69, P = 0.036, η2p = 0.11. As expected, there were also 
interactions between time of day and altitude, F(1,40) = 29.43, 
P < 0.001, η2p = 0.42, with a bigger drop at night as altitude 
increases, and between age group and altitude, F(1,40) = 4.51, 
P = 0.040, η2p = 0.10, with altitude decreases in SpO2 greater in 
infants than in children.
Differences in diurnal and nocturnal mean SpO2 values could 
not be explained by history of snoring, overweight, or obesity, 
because there were no age group or altitude differences in the 
proportion of participants with these problems, all P > 0.05.
Measures of Nocturnal SpO2 Stability
Within-Altitude Comparisons, by Age Group
There were notable developmental differences in nocturnal 
SpO2 stability, measured by the delta (12s) and 3% desatura-
tion indices (Table 2). As previously observed, at LA, develop-
mental differences were evident between infants and children: 
3% dips, TJT = 21.0, z = −2.3, P = 0.019, and delta 12s index, 
TJT = 7.0, z = −3.3, P = 0.001. For both measures, there was 
a reduction in these indices with age. However, this develop-
mental difference was more striking at HA: 3% dips, TJT = 73.0, 
z = −2.7, P = 0.008; and delta 12s, TJT = 49.0, z = −3.7, P < 0.001, 
where very highly significant differences were noted between 
infants and both children and adolescents, but not between 
children and adolescents.
Within Age Group Comparisons by Altitude
Within age groups, altitude effects were apparent, with in-
creasing variability noted in both infants: 3% dips, LA versus 
HA: TJT = 84.0, z = 3.6, P < 0.001; delta 12s, TJT = 82.0, z = 3.4, 
P = 0.001, and within children, LA versus MA versus HA: 3% 
dips, TJT = 342.0, z = 5.2, P < 0.001,; delta 12, TJT = 375.0, z = 5.1, 
P < 0.001, where variability increased linearly with altitude.
Two-Way Comparisons of Altitude by Age Group
This was confirmed by a very strong age group (infants, chil-
dren) by altitude (LA, HA) interaction in both 3% desaturation 
F(1, 41) = 35.91, P < 0.001, η2p = 0.47 and delta 12s indices, 
F(1, 41) = 24.58, P < 0.001, η2p = 0.38.
Exposure to Low Nocturnal SpO2
Within Age Group, Comparisons by Altitude
Within infants, at HA a greater percentage of time was spent 
with SpO2 < 90% and < 80% saturation, relative to LA, 
TJT = 84.0 and 78.0, both z = 3.7, P < 0.001 (Table 2). Within 
children, at HA a greater percentage of time was spent at 
SpO2 < 90% saturation, TJT = 351.0, z = 4.4, P < 0.001, but 
not SpO2 < 80%, TJT = 207.5.0, z = 0.5, P = 0.631, with pair-
wise comparisons confirming increasing time spent below 
threshold from LA to MA to HA. Of note, at HA, two infants 
and one child spent > 30 min with SpO2 < 80%. Diurnal SpO2 
values in these three participants were indistinguishable from 
age and altitude peers (92%, 94%, and 94%, respectively), yet 
they experienced 37.1 (7.9%), 98.7 (19.2%), and 37.5 (8.3%) 
min, respectively, with SpO2 < 80% at night.
Within Altitude, Comparisons by Age Group
Within HA participants, time spent at SpO2 < 80% saturation, 
TJT = 91.0 z = −2.2, P = 0.030, and < 90%, TJT = 64.0, z = −3.2, 
P = 0.001, was significantly different, driven by significantly 
greater time spent below 90% in HA and MA children than in 
LA (where HA and MA did not differ), and significantly greater 
time spent below 80% in a linear fashion across LA, MA, and 
HA. Comparisons within low altitude participants were not 
conducted, given very low levels of exposure to low nocturnal 
SpO2 (see Table 2), consistent with previous literature.11
Figure 2—Developmental trajectory of diurnal and nocturnal 
oxyhemoglobin saturation (SpO2) values. Difference between 
diurnal and nocturnal mean oxyghemoglobin saturation at three 
different altitudes by age group (infants, 6–12 mo old; children, 
4–10 years old; adolescents, 13–17 years old). Altitude values are: 
high > 3,650 m, moderate 2,500 m, and low 500 m. Error bars are 
standard errors.
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DISCUSSION
Consistent with previous studies, we report a decrease in di-
urnal SpO2 with increasing altitude in infants and children. We 
also report novel findings of developmental maturation of noc-
turnal oxyhemoglobin saturation from infancy to childhood in 
HA Andean natives. Of particular note, the degree of diurnal 
to nocturnal SpO2 difference at HA is greatest in infancy and 
decreases with progression to childhood, with no further gains 
into adolescence.
Tissue oxygenation at HA is determined by total oxygen 
carrying capacity. Oxygen carrying capacity is determined by 
the following equation: 
(1.34 × HC × SpO2% × 0.01) + (0.023 × PaO2), 
where HC is hemoglobin concentration. Hemoglobin carries 
98% of oxygen in the blood, with the remainder dissolved in 
plasma. Andean HA residents increase their oxygen-carrying 
capacity through erythropoiesis which, along with increased 
tissue perfusion and 2-3–diphosphoglycerate (DPG) levels, in-
creases tissue oxygen delivery. Could these adaptive mecha-
nisms fully compensate for the degree of diurnal- nocturnal 
difference in SpO2 observed in this study? Healthy adults take 
up to 4 days to increase 2-3-DPG levels when exposed to hy-
pobaric hypoxia at 3,400 m, making this an unlikely source 
of nocturnal compensation.14 Similarly, hemoglobin concentra-
tion does not fluctuate over 24 h. Our data, therefore, suggest 
a genuine decrease in oxygen- carrying capacity in HA chil-
dren at night. Lower metabolic demand in sleep may offset the 
effect of this reduction in oxygen carriage, or tissue oxygen 
delivery may be maintained through other mechanisms. How-
ever, the fact that both nocturnal mean SpO2 and indices of 
stability of SpO2 improve with advancing age at HA suggests 
two possible hypotheses.
First, our SpO2 findings may be a marker of maturation of 
ventilatory control at HA. Periodic breathing (PB) is com-
monly reported in healthy, adult, altitude sojourners and 
causes significant oscillations of nocturnal SpO2 and an in-
creasing divergence of diurnal and nocturnal SpO2.15 Similar 
findings in our data, most striking in infants at HA, suggest 
PB as a possible explanation. In the first 2 w of life, 79% of 
healthy term infants at sea level have PB. By 39 to 52 w of age 
(the age of infants in our study) only 29% retain PB, typically 
for less than 1% of total sleep time.16 Thus, HA infants may 
have delayed maturation of respiratory control, with persistent 
PB into late infancy. We did not measure daytime naps, but 
lower diurnal SpO2 values in napping versus awake infants at 
HA have previously been reported.6 Infants spend more than 
half of their lives asleep, increasing the potential for hypoxic 
exposure. It is feasible that such exposure could recalibrate the 
carotid body,17,18 and predispose Andeans to later ventilatory 
instability. This hypothesis is supported by findings in adult, 
Andean, HA natives. Coote et al. reported PB with marked, 
arterial oxygen desaturation, in 8 healthy, young men living at 
4,380 m,19 later confirmed by Spicuzza and colleagues20 in 20 
men (mean age 38 y) at the same altitude (Figure 1B). In con-
trast, other authors have noted only minor sleep abnormalities 
in these populations.21 Such contradictory findings may reflect 
sampling from different ancestry populations, highlighting the 
importance of reporting genetic ancestry.
Another plausible explanation relates to the affinity of he-
moglobin for oxygen according to the partial pressure of arte-
rial oxygen (PaO2). The steep slope of the oxygen dissociation 
curve at lower SpO2 predicts that small perturbations in PaO2, 
due to sleep-related fluctuations in ventilation, would lead to 
larger drops in SpO2. This provides a possible explanation for 
the higher delta 12s index and 3% desaturation indices seen at 
all ages at HA. Other authors have noted SpO2 instability in 
children resident at higher altitude (1,600 m) that was not ex-
plained by PB,22 although this location was below the 2,500-m 
threshold used to define HA (Figure 1A). According to this 
hypothesis, the lower diurnal baseline in infants would be pre-
dicted to predispose to greater instability at night. Lower base-
line SpO2 in infants, in turn, could be explained by persistently 
increased pulmonary arterial pressure as previously described 
at HA in Andean infants, albeit at higher altitudes (> 4,000 m) 
than the current sample.23
The implications of relative nocturnal hypoxia in HA chil-
dren deserve consideration. The developing brain is dependent 
on a continuous supply of oxygen.24 Alterations in nocturnal 
oxygen-carrying capacity at altitude may impair neurocogni-
tive development, as evidenced by the extensive literature on 
the neurocognitive cost of chronic and intermittent hypoxia 
in childhood.25 Conversely, nocturnal respiratory instability 
could serve as adaptive preparation for HA survival through 
the calibration of physiological equilibrium between the up-
regulation of hypoxia-protective pathways (e.g., hypoxia 
inducible factors) and the reduction of potential harm from 
excessive erythropoiesis.26 Indeed, we have reported relatively 
subtle cognitive impairments in this population of HA chil-
dren,8,9 suggesting the presence of compensatory mechanisms. 
Such mechanisms could be challenged in children with addi-
tional constraints, such as those with congenital or acquired 
brain injury or underlying cardiorespiratory disease, and this 
merits further study.
Limitations of This Study
The lack of measures of respiratory effort and airflow to iden-
tify apnea make the interpretation of our findings speculative. 
However, in a healthy child, SpO2 is a marker of tissue oxygen 
availability independent of body size and, importantly, hemo-
globin does not have the response kinetics to accommodate the 
day-night variation we have described.
We studied nocturnal SpO2 in the absence of objective sleep 
measures and, therefore, differences between diurnal and noc-
turnal measures are inferred to be related to sleep. However, 
these differences are consistent with participants sleeping 
during the recordings in the absence of any other viable expla-
nation. Indeed, failure to extract periods of wake from the data, 
particularly in infants who may have awakened for feeds at 
night, will have under-estimated diurnal-nocturnal differences, 
thus strengthening our findings.
The high prevalence of reported snoring compared to Euro-
pean samples could indicate sampling bias. However, our data 
are consistent with a Chilean study which reported habitual 
snoring in 18% of children aged 7–17 y.27. Furthermore, the 
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lack of altitude-related differences in snoring history suggests 
that HA findings cannot be attributed to snoring.
Our original aim was to measure oximetry across all ages. 
Delays in importing equipment limited assessment at LA to 
infants and children. However, there was no a priori expec-
tation of developmental differences in sleep related SpO2 or 
ventilatory control between children and adolescents at LA. 
Importantly, data were collected for all ages at HA. Sample 
sizes in each age and altitude subgroup were also smaller than 
intended; nonetheless, they were sufficient to demonstrate sig-
nificant age and altitude effects between infants and children.
Notwithstanding these limitations, our findings are not only 
of academic interest to HA researchers but are also clinically 
relevant to pediatric critical care medicine. Children with 
respiratory disease may experience profound nocturnal oxy-
hemoglobin desaturation at HA, compromising an already 
constrained system. Andean children with sleep-disordered 
breathing living at only 2,240 m who experienced > 43% of the 
night with SpO2 < 90% had pulmonary arterial hypertension 
on echocardiography.28 In our study, at HA, infants spent a me-
dian of 79.7% of the night with SpO2 < 90% compared to 33.5% 
of children and 7.6% of adolescents. Based on studies of diurnal 
SpO2 measurements, previous authors have recommended that 
oxygen therapy should be initiated for SpO2 < 85% in HA hos-
pital pediatric settings.29 Our data indicate that healthy infants 
living at HA will often experience oxyhemoglobin desatura-
tion in sleep below this threshold. Thus, these guidelines may 
not apply to Andean populations.
These novel findings indicate potentially significant noc-
turnal oxyhemoglobin desaturation in healthy Andean HA 
dwelling children with mixed European and Amerindian an-
cestry. Increased SpO2 variability at HA could be explained 
by a number of mechanisms and appears to stabilize across 
childhood. Further studies could usefully replicate our find-
ings and establish normative, sleep-related SpO2 data in child-
hood at HA, alongside characterization of respiratory patterns 
with polysomnography.
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